These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36828188)

  • 1. GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis.
    Deng X; Ma J; Zhou W; Yuan Y; Wang B; Meng X
    Lab Invest; 2023 Jun; 103(6):100122. PubMed ID: 36828188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression.
    Ma J; Zhou W; Yuan Y; Wang B; Meng X
    Cancer Gene Ther; 2023 Aug; 30(8):1072-1083. PubMed ID: 37037907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
    Deng M; Wang J; Chen Y; Zhang L; Xie G; Liu Q; Zhang T; Yuan P; Liu D
    Mol Med Rep; 2016 Aug; 14(2):1523-30. PubMed ID: 27314680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling.
    Yu C; Cao H; He X; Sun P; Feng Y; Chen L; Gong H
    Biomed Pharmacother; 2017 Dec; 96():1109-1118. PubMed ID: 29196103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
    Wang H; Chen H; Zhou H; Yu W; Lu Z
    Oncol Res; 2017 Nov; 25(9):1431-1440. PubMed ID: 28109073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.
    Zhang LP; Li WJ; Zhu YF; Huang SY; Fang SY; Shen L; Gao YL
    Int J Clin Exp Pathol; 2015; 8(5):4535-44. PubMed ID: 26191143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
    Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
    Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cyclin-dependent kinase inhibitor 3 in the proliferation and migration of renal cell carcinoma.
    Ni C; Guo Z; Bu H; Zhao X; Bao M; Ding L; Liang C; Tang Q; Li J
    Chem Biol Interact; 2024 Jul; 397():111092. PubMed ID: 38825053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN3 regulates cisplatin resistance to colorectal cancer through TIPE1.
    Li WH; Zhang L; Wu YH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3614-3623. PubMed ID: 32329836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
    Dai W; Miao H; Fang S; Fang T; Chen N; Li M
    Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.
    Li Y; Ji S; Fu LY; Jiang T; Wu D; Meng FD
    Oncol Res; 2017 May; 25(5):721-731. PubMed ID: 27983933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CDKN3 in cervical cancer.
    Berumen J; Espinosa AM; Medina I
    Expert Opin Ther Targets; 2014 Oct; 18(10):1149-62. PubMed ID: 25152075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.
    Xing C; Xie H; Zhou L; Zhou W; Zhang W; Ding S; Wei B; Yu X; Su R; Zheng S
    Biochem Biophys Res Commun; 2012 Mar; 420(1):29-35. PubMed ID: 22390936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated transcriptomics explored the cancer-promoting genes CDKN3 in esophageal squamous cell cancer.
    Wang W; Liao K; Guo HC; Zhou S; Yu R; Liu Y; Pan Y; Pu J
    J Cardiothorac Surg; 2021 May; 16(1):148. PubMed ID: 34044866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic studies of cyclin-dependent kinase inhibitor 3 (CDKN3) in colorectal cancer.
    Yang C; Sun JJ
    Asian Pac J Cancer Prev; 2015; 16(3):965-70. PubMed ID: 25735390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.
    Barrón EV; Roman-Bassaure E; Sánchez-Sandoval AL; Espinosa AM; Guardado-Estrada M; Medina I; Juárez E; Alfaro A; Bermúdez M; Zamora R; García-Ruiz C; Gomora JC; Kofman S; Pérez-Armendariz EM; Berumen J
    PLoS One; 2015; 10(9):e0137397. PubMed ID: 26372210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis.
    Chen Q; Chen K; Guo G; Li F; Chen C; Wang S; Nalepa G; Huang S; Chen JL
    PLoS One; 2014; 9(10):e111611. PubMed ID: 25360622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer.
    Cress WD; Yu P; Wu J
    Int J Biochem Cell Biol; 2017 Oct; 91(Pt B):98-101. PubMed ID: 28504190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation.
    Wang L; Sun L; Huang J; Jiang M
    Cell Prolif; 2011 Jun; 44(3):291-9. PubMed ID: 21535270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.